As phosphorylation of H2AX (γ-H2AX) is a hall marker of DSBs (35), we conducted an immunofluorescence assay to determine the number of γ-H2AX foci after 24 h of treatment with IR and inhibitors in ESCC cells. The gene discussed is H2AX; the disease is esophageal squamous cell carcinoma.